Associated Papers
Persistent response of furmonertinib plus anlotinib in a lung adenocarcinoma patient with an EGFR exon 20 insertion mutation: A case report.
Chen X et al.
Frontiers in Pharmacology, 2023
Comprehensive profiling and quantitation of oncogenic mutations in non small-cell lung carcinoma using single molecule amplification and re-sequencing technology.
Zhang S et al.
Oncotarget, 2016
27409166 (PubMed )
Supplement: oncotarget-07-50477-s001.pdf
Select a paper to view details